下子宫部分参与子宫内膜癌的意义

Sharon Davidesko1, Mihai Meirovitz1, Ruthy Shaco-Levy2

  • 1Department of Obstetrics and Gynecology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel; Department of Gynecological Oncology, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva, Israel.

概括

在子宫内膜癌中,下子宫段参与 (LUSI) 与较差的结果有关,包括较短的无进展生存期 (PFS) 和整体生存期 (OS). 这一发现表明LUSI可能需要考虑辅助治疗决策.